Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Liang Cheng(Brown University), Rodolfo Montironi(Marche Polytechnic University)
Cited by 404
Related Papers
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
|Cells|2020|256
The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
|Histopathology|2016|236
Frequent <i>FGFR3</i> mutations in urothelial papilloma
|The Journal of Pathology|2002|189
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
|Journal of Clinical Investigation|2016|175